• Home
  • Search Results
  • Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.

Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.

PloS one (2015-02-28)
Jamie Merves, Prasanna Modayur Chandramouleeswaran, Alain J Benitez, Amanda B Muir, Anna J Lee, Diana M Lim, Kara Dods, Isha Mehta, Eduardo D Ruchelli, Hiroshi Nakagawa, Jonathan M Spergel, Mei-Lun Wang

Eosinophilic Esophagitis (EoE) is a chronic allergic disorder, whose pathobiology is incompletely understood. Histamine-producing cells including mast cells and basophils have been implicated in EoE. However, very little is currently known about the role of histamine and histamine receptor (HR) expression and signaling in the esophageal epithelium. Herein, we characterized HR (H1R, H2R, H3R, and H4R) expression in human esophageal biopsies and investigate the role of histamine signaling in inducible cytokine expression in human esophageal epithelial cells in vitro. HR expression was quantified in esophageal biopsies from non-EoE control (N = 23), inactive EoE (<15 eos/hpf, N = 26) and active EoE (>15 eos/hpf, N = 22) subjects using qRT-PCR and immunofluorescent localization. HR expression and histamine-mediated cytokine secretion were evaluated in human primary and telomerase-immortalized esophageal epithelial cells. H1R, H2R, and H4R expression were increased in active EoE biopsies compared to inactive EoE and controls. H2R was the most abundantly expressed receptor, and H3R expression was negligible in all 3 cohorts. Infiltrating eosinophils expressed H1R, H2R, and H4R, which contributed to the observed increase in HR in active subjects. H1R and H2R, but not H3R or H4R, were constitutively expressed by primary and immortalized cells, and epithelial histamine stimulation induced GM-CSF, TNFα, and IL-8, but not TSLP or eotaxin-3 secretion. Epithelial priming with the TLR3 ligand poly (I:C) induced H1R and H2R expression, and enhanced histamine-induced GM-CSF, TNFα, and IL-8 secretion. These effects were primarily suppressed by H1R antagonists, but unaffected by H2R antagonism. Histamine directly activates esophageal epithelial cytokine secretion in vitro in an H1R dependent fashion. However, H1R, H2R and H4R are induced in active inflammation in EoE in vivo. While systemic antihistamine (anti-H1R) therapy may not induce clinical remission in EoE, our study suggests that further study of histamine receptor signaling in EoE is warranted and that targeting of additional histamine receptors may lead to novel treatment strategies for this important disease.

Product Number
Product Description

Cimetidine for peak identification, European Pharmacopoeia (EP) Reference Standard
Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard
Formaldehyde solution, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Histamine, ≥97.0%
Citric acid trisodium salt, anhydrous, ≥98% (GC)
Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material
Formaldehyde solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Citrate Concentrated Solution, BioUltra, for molecular biology, 1 M in H2O
Formaldehyde solution, meets analytical specification of USP, ≥34.5 wt. %
Formaldehyde solution, for molecular biology, 36.5-38% in H2O
Formaldehyde solution, tested according to Ph. Eur.
Formaldehyde solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Citrate Concentrated Solution, BioReagent, suitable for coagulation assays, 4 % (w/v)
Histamine, analytical standard
Cimetidine, United States Pharmacopeia (USP) Reference Standard
Sodium Citrate, Pharmaceutical Secondary Standard; Certified Reference Material
Formaldehyde solution, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Cimetidine, European Pharmacopoeia (EP) Reference Standard